Table 1 Demographic, clinical and histopathological data of patients.

From: Prediction of recurrence using hematologic and urinary markers in intravesical Bacillus calmette Guerin treated bladder cancer

 

Recurrence negative n:65(%)

Recurrence positive n:12(%)

p

Sex, F/M

7/58

3/9

0.18*

Primary pathology

  

0.56*

TaLG

7 (10.8%)

2 (16.7%)

 

TaHG

17 (26.2%)

2 (16.7%)

 

T1LG

6 (9.2%)

0 (0%)

 

T1HG

35 (53.8%)

8 (66.7%)

 

Concomitant CIS

10 (15.4%)

2 (16.7%)

0.91*

Smoke

  

0.17*

Non-smoker

11 (17.5%)

5 (41.7%)

 

Ex-smoker

39 (61.9%)

5 (41.7%)

 

Smoker

13 (20.6%)

2 (16.7%)

 

Age, year

66.085 ± 9.783

68.417 ± 6.908

0.5 †

Number of Tumors

1.848 ± 1.064

1.5 ± 0.798

0.29 †

Tumor size(cm)

4.229 ± 1.901

4.792 ± 1.499

0.12 †

Follow-up period, (months)

30.966 ± 5.179

28.5 ± 3.261

0.17 †

  1. * Chi-Square test † Mann Whitney U test.
Back to article page